International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
نویسنده
چکیده
D. FAR GE ,* 1 P . DEBOURDEAU, 1 M. BECKERS ,§ C . B AGL IN ,– R . M. BAUERSACHS ,** B . BRENNER , D. BR ILHANTE , A. FALA NGA, §§ G . T . GEROTZA F IA S ,–– N. HA IM,*** A . K . KAKKAR , A. A . K H ORA NA , R . LECUMB ERR I , §§§ M. MANDALA ,––– M. MA RTY , **** M. MONREAL , S . A . MOUSA , §§§§ S . NOBLE ,–––– I . PA B INGER ,* **** P . PRANDONI , M. H. PR INS , M. H. QA RI , §§§§ § M. B . STR E I FF ,––––– K . SYR I GOS ,* **** * H. B OUNAMEAUX 1
منابع مشابه
Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients.
Symptomatic venous thromboembolism (VTE) occurs 4-7 times more frequently in cancer patients as compared to non-cancer patients. A significant number of risk factors, which can be subcategorised as patient-, cancer- or treatment-related, have been shown to influence the risk of VTE during malignancy and further incorporated in risk-assessment models. Safe and efficient thromboprophylaxis regime...
متن کاملRecurrent Venous Thromboembolism as the Initial Clinical Presentation of Gastric Cancer: A Case Report
Pulmonary thromboembolism (PTE) is a clinically critical disease, misdiagnosis or delayed diagnosis of which can lead to increased rate of mortality. For prevention of recurrence of PTE, recognition of its risk factors or underlying diseases is of great importance. PTE is common in patients with cancer and has high morbidity and mortality rates. Although cancer is a lethal condition, PTE accele...
متن کاملRivaroxaban versus enoxaparin for treatment of patients with nonhematologic cancer with venous thromboembolism a randomized clinial trial
Background: Low-Molecular-Weight Heparin (LMWH) is recommended as the first-line treatment in patients with active cancer and venous thromboembolism (VTE), but many patients prefer to take oral anticoagulants and non-injectable forms with more reasonable price. Venous thromboembolism is a very common comorbidity in patients with cancer. Therefore, the aim of this study was to evaluate the effic...
متن کاملImplementing Thrombosis Guidelines in Cancer Patients: A Review
Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as the need for adequate prevention and treatment. Management of venous thromboembolism in patients with cancer requires the coordinated efforts ...
متن کاملInternational clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at an increased risk of developing VTE and are more likely to have a recurrence of VTE and bleeding while taking anticoagulants. Management of VTE in patients with cancer is a major therapeutic challenge and remains suboptimal worldwide. In 2013, the International Initiative on Thrombos...
متن کاملThe NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
The risk for venous thromboembolism (VTE) is high in hospitalized cancer patients, and is associated with an elevated risk for recurrent thrombosis, bleeding complications, and use of health care resources. Thromboembolism is the second leading cause of death in hospitalized cancer patients. Thromboprophylaxis with unfractionated heparin or low-molecular-weight heparins has been clinically prov...
متن کامل